期刊文献+

奥沙利铂对肝癌细胞HuH-7细胞周期的影响 被引量:11

Effect of Oxaliplatin on Cell Cycle of Hepatocellular Carcinoma Cell Line HuH-7
下载PDF
导出
摘要 目的探讨奥沙利铂(Oxaliplatin,L-OHP)对人肝癌细胞株HuH-7细胞周期的影响及其相关机制,为其应用于原发性肝细胞癌临床治疗提供理论依据。方法 MTT方法检测L-OHP对肝癌细胞HuH-7生长的抑制作用;流式细胞术(FCM)检测L-OHP诱导HuH-7细胞周期阻滞的作用;RT-PCR和Western blot方法观察L-OHP对细胞周期调节因子Cyclin D1、CDK2、CDK4及p16、p21、p53表达的影响。结果 MTT结果显示L-OHP对HuH-7细胞增殖抑制率随药物浓度增加及作用时间延长有升高趋势,呈时间剂量依赖性。L-OHP能够诱导HuH-7细胞周期阻滞于S期,并可下调CDK4和Cyclin D1蛋白的表达,上调p21蛋白的表达,低浓度上调p53表达而高浓度下调p53表达,CDK2和p16表达无明显变化。结论 L-OHP可能通过影响CDK4、Cyclin D1及p21的活性使HuH-7细胞阻滞在S期,从而抑制肝癌细胞HuH-7的增殖。 Objective To study the effect of Oxaliplatin(L-OHP)on cell cycle of hepatocellular carcinoma(HCC)cell line HuH-7 and the involved mechanism in order to provide the theoretical foundation for the chemotherapy of HCC.Methods Inhibitory effect of L-OHP on the proliferation of HuH-7 cells was determined by MTT assay.Cell cycle distribution was shown by flow cytometry.Cyclin D1,CDK2,CDK4,p16,and p21 expression levels were detected by uisng RT-PCR and Western blot.Results MTT method revealed that L-OHP could inhibit the proliferation of HCC HuH-7 cells in a dose-and time-dependent manner.L-OHP could cause S cell cycle arrest in HuH-7 cells,down-regulate the levels of CDK4 and Cyclin D1,and up-regulate the level of p21.L-OHP could up-regulate the level of p53 in low concentration and down-regulate the level of p53 in high concentration.Meanwhile,there were no noticeable changes in CDK2 and p16.Conclusion L-OHP can inhibit the proliferation of HuH-7 cells by inducing cell blockage at S stage,which may be resulted from the activity of CDK4,Cyclin D1 and p21.
出处 《华中科技大学学报(医学版)》 CAS CSCD 北大核心 2012年第4期445-449,共5页 Acta Medicinae Universitatis Scientiae et Technologiae Huazhong
基金 安徽省自然科学基金资助项目(No.1208085MH170)
关键词 奥沙利铂 细胞周期 肝癌 Oxaliplatin; cell cycle; hepatocellular carcinoma
  • 相关文献

参考文献10

  • 1Yang J D,Roberts L R.Hepatocellular carcinoma:A global view[J].Nat Rev Gastroenterol Hepatol,2010,7(8):448-458.
  • 2Grávalos C,García-Escobar I,García-Alfonso P,et al.Adj-uvant chemotherapy for stages Ⅱ,Ⅲ and Ⅳ of colon cancer[J].Clin Transl Oncol,2009,11(8):526-533.
  • 3Yen Y,Lim D W,Chung V,et al.PhaseⅡstudy of oxaliplatin in patients with unresectable,metastatic,or recurrent hepatocellular cancer:a California Cancer Consortium Trial[J].Am J Clin Oncol,2008,31(4):317-322.
  • 4Louafi S,Boige V,Ducreux M,et al.Gemcitabine plus oxaliplatin(GEMOX)in patients with advanced hepatocellular carcinoma(HCC):results of a phase Ⅱ study[J].Cancer,2007,109(7):1384-1390.
  • 5Voland C,Bord A,Péleraux A,et al.Repression of cell cycle-related proteins by oxaliplatin but not cisplatin in human colon cancer cells[J].Mol Cancer Ther,2006,5(9):2149-2157.
  • 6Evan G I,Vouaden K H.Proliferation,cell cycle and apoptosis in cancer[J].Nature,2001,411(6835):342-348.
  • 7Takasu S,Tsukamoto T,Ushijima T,et al.Cyclin D1 overexpression in N-methyl-N′-nitro-N-nitrosoguanidine-induced rat gastric adenocareinomas[J].Exp Toxicol Pathol,2007,59(3/4):171-175.
  • 8Kao J T,Chuah S K,Huang C C,et al.P21/WAF1 is an independent survival prognostic factor for patients with hepatocellular carcinoma after resection[J].Liver Int,2007,27(6):772-781.
  • 9谢琼慧,何星星,常莹,蒋翔,林菊生.HBx基因下调miR-192对人肝癌细胞株HepG2周期的影响[J].华中科技大学学报(医学版),2011,40(3):249-254. 被引量:6
  • 10Ecke T H,Schlechte H H,Schiemenz K,et al.TP53 gene mutations in prostate cancer progression[J].Anticancer Res,2010,30(5):1579-1586.

二级参考文献19

  • 1Bouchard M J, Schneider R J. The enigmatic X gene of hepati- tis B virus[J]. J Virol,2004,78(23) :12725-12734.
  • 2Esquela-Kerscher A, Slack F J. Oncomirs-microRNAs with a role in cancer[J]. Nat Rev Cancer, 2006,6 (4) : 259-269.
  • 3Zimmerman A L, Wu S. MicroRNAs, cancer and cancer stem cells[J]. Cancer Lett,2011,300(1) : 10-19.
  • 4Varnholt H,Drebber U, Schulze F, et al. MicroRNA gene ex- pression profile of hepatitis C virus-associated hepatoeellular carcinoma[J]. Hepatotogy,2008,47(4) : 1223-1232.
  • 5Ladeiro Y, Couchy G, Balabaud C, et al. MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations[J]. Hepatol- ogy, 2008,47(6) : 1955-1963.
  • 6Barad O, Meiri E, Avniel A, et al. MicroRNA expression de- tected by oligonucleotide microarrays: system establishment and expression profiling in human tissues[J]. Genome Res, 2004,14(12) :2486-2494.
  • 7Wang Y,Lu Y,Toh S T,et al. Lethal-7 is down-regulated by the hepatitis B virus X protein and targets signal transducer and acti- vator of transcription 3[J]. J Hepatol, 2010,53 (1) : 57-66.
  • 8Yang L, Ma Z, Wang D,et al. MicroRNA-602 regulating tum- or suppressive gene RASSF1A is overexpressed in hepatitis B virus-infected liver and hepatocellular eareinoma[J]. Cancer Biol Ther,2010,9(10) :803-808.
  • 9Ganem D,Prince A M. Hepatitis B virus infection-natural hi- story and clinical consequences[J]. N Engl J Med, 2004,350 (11) :1118-1129.
  • 10Matsuda Y,Iehida T. Impact of hepatitis B virus X protein on the DNA damage response during hepatocarcinogenesis[J]. Med Mol Morphol, 2009,42(3) : 138-142.

共引文献5

同被引文献141

  • 1张燕,左国庆,汤为学.奥沙利铂对人肝癌细胞株HepG2体外增殖的影响[J].中华肝脏病杂志,2004,12(6):374-375. 被引量:40
  • 2冯觉平,于世英,王亚萍,袁响林,李敏,方静.奥沙利铂对肝癌细胞HepG2生物学行为的影响[J].肿瘤,2010,30(9):753-757. 被引量:3
  • 3潘雪莲,周青山,杜大萍.丹参酮ⅡA对糖尿病大鼠神经病理性疼痛的影响[J].中华麻醉学杂志,2006,26(8):692-695. 被引量:18
  • 4鲁东,吕维富.肝癌血供研究进展[J].中国介入影像与治疗学,2007,4(3):227-231. 被引量:17
  • 5Parkin D M,Bray F,Ferlay J,et al.Estimating the world cancer burden:Globocan 2000[J].Int J Cancer,2001,94(2):153-156.
  • 6Stein U,Walther W,Arlt F,et al.MACC1,a newly identified key regulator of HGF-MET signaling,predicts colon cancer metastasis[J].Nat Med,2009,15(1):59-67.
  • 7O′connell J B,Maggard M A,Liu J H,et al.A report card on outcomes for surgically treated gastrointestinal cancers:are we improving?[J].J Surg Res,2004,121(2):214-221.
  • 8Yang L Y,Fang F,Ou D P,et al.Solitary large hepatocellular carcinoma:a specific subtype of hepatocellular carcinoma with good outcome after hepatic resection[J].Ann Surg,2009,249(1):118-123.
  • 9Cherqui D,Laurent A,Mocellin N,et al.Liver resection for transplantable hepatocellular carcinoma:long-term survival and role of secondary liver transplantation[J].Ann Surg,2009,250(5):738-746.
  • 10Ma P C,Maulik G,Christensen J,et al.c-Met:structure,functions and potential for therapeutic inhibition[J].Cancer Metastasis Rev,2003,22(4):309-325.

引证文献11

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部